兽用抗生素和抗菌剂市场规模、份额和成长分析（按类型、剂型、动物和地区划分）—产业预测（2026-2033 年）

全球兽用抗生素和抗菌药物市场预计到 2024 年将达到 47.8 亿美元，到 2025 年将达到 49.5 亿美元，到 2033 年将达到 65.2 亿美元，预测期（2026-2033 年）的复合年增长率为 3.5%。

全球兽用抗生素和抗菌药物市场在动物医药领域发挥着至关重要的作用，其主要驱动力是肉类、牛奶和鸡蛋消费量成长带来的动物性蛋白质需求快速成长。而全球人口成长和可支配收入增加又推动了畜牧业的扩张，进而刺激了这项需求的激增。同时，动物感染疾病（例如感染疾病和胃肠道感染疾病）的传播对动物健康构成重大威胁，增加了对用于疾病预防和治疗的抗生素和抗菌药物的需求。此外，人们对动物福利的日益关注以及限制通用感染疾病传播的必要性，凸显了这些产品在维持动物健康、生长和生产力方面的重要性，进一步巩固了它们在市场中的关键地位。

兽用抗生素和抗菌药物市场驱动因素

动物感染疾病（例如禽流感、口蹄疫和猪霍乱）的日益流行凸显了使用抗生素和抗菌药物预防和控制疫情的必要性。疾病造成的经济损失推动了对这些产品的需求，尤其是在这些疾病高发生率地区。这种不断增长的需求主要源于保护动物健康和确保畜牧业生产力的需要。因此，随着动物健康日益受到重视，为应对这些紧迫的挑战，抗生素和抗菌药物市场也持续扩张。

动物用抗生素和抗菌剂市场的限制

随着消费者对食品安全和永续性的偏好不断提高，对无抗生素畜产品的需求日益增长。消费者对抗生素在畜牧生产的影响认知不断加深，生产者面临越来越大的压力，不得不采用无抗生素的生产方式。这种转变对兽用抗生素和抗菌药物的需求产生了负面影响，因为生产者需要调整其生产方式以适应市场趋势和消费者期望。因此，畜牧业内部出现了一股明显的趋势，即探索强调永续性和减少抗生素使用的替代疾病预防和生长促进策略，这进一步抑制了传统抗生素的市场需求。

动物抗生素和抗菌剂市场趋势

兽用抗生素和抗菌药物市场正经历显着的变革，其驱动力在于人们对合理用药的日益关注以及对抗生素替代品的探索。消费者对抗菌素抗药性（AMR）的认识不断提高，以及监管压力，迫使相关人员实施创新策略，在保障动物健康的同时降低AMR风险。因此，益生菌、益生元、植物性抗菌剂和疫苗等替代品越来越受到关注，它们正逐渐成为提高牲畜生产力和福祉的有效解决方案。这一趋势反映了人们正朝着永续畜牧业实践迈进，力求在确保食品安全和公众健康的同时，满足消费者和监管机构日益增长的期望。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球动物抗生素和抗菌剂市场按类型划分，复合年增长率（2026-2033 年）

• 四环霉素
• 青霉素
• 磺胺类药物
• 大环内酯类
• Aminoglycosides
• 林可酰胺类
• Fluoroquinolones
• 头孢菌素
• 其他抗生素和抗菌剂

全球动物抗生素和抗菌剂市场按剂型划分，复合年增长率（2026-2033 年）

• 预混合料
• 口服粉剂
• 口服液
• 注射
• 其他的

全球动物抗生素和抗菌剂市场（按物种划分），复合年增长率（2026-2033 年）

• 食用动物
  • 牛
  • 猪
  • 家禽
  • 绵羊/山羊
  • 其他食用动物
• 宠物
  • 狗
  • 猫
  • 马
  • 其他宠物

全球动物抗生素和抗菌剂市场规模、复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
• 2023-2025年营收年比比较

主要企业简介

• Zoetis Inc.（USA）
• Merck & Co., Inc.（USA）
• Elanco Animal Health Incorporated（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Vetoquinol（France）
• Bayer AG（Germany）
• Novartis AG（Switzerland）
• Eli Lilly and Company（USA）
• Sanofi（France）
• Intervet Inc.（Netherlands）
• Alltech（Ireland）
• Huvepharma（Bulgaria）
• Kemin Industries（USA）
• Novus International（USA）
• Biomin Holding GmbH（Austria）
• ADM Animal Nutrition（USA）
• Adisseo（France）
• DSM（Netherlands）

结论与建议

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.78 Billion in 2024 and is poised to grow from USD 4.95 Billion in 2025 to USD 6.52 Billion by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

The global market for animal antibiotics and antimicrobials plays a crucial role in veterinary pharmaceuticals, primarily driven by the surging demand for animal protein as meat, milk, and eggs consumption escalates. This spike is influenced by a growing global population and increased disposable incomes, prompting a rise in livestock production. Simultaneously, the prevalence of infectious diseases in animals, such as respiratory and gastrointestinal infections, poses significant risks to animal health, thereby elevating the demand for antibiotics and antimicrobials for disease prevention and treatment. Furthermore, heightened awareness regarding animal welfare and the need to limit zoonotic disease transmission underscores the importance of these products in ensuring optimal animal health, growth, and productivity, reinforcing their indispensable role in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Antibiotics and Antimicrobials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Antibiotics and Antimicrobials Market Segments Analysis

Global Animal Antibiotics And Antimicrobials Market is segmented by type, delivery, animal and region. Based on type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins and other antimicrobials and antibiotics. Based on delivery, the market is segmented into premixes, oral powder, oral solution, injection and others. Based on animal, the market is segmented into food-producing animals and companion animals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Animal Antibiotics and Antimicrobials Market

The rising prevalence of infectious diseases in animals, including avian influenza, foot-and-mouth disease, and swine fever, highlights the critical need for antibiotics and antimicrobials to prevent and manage these outbreaks. The economic repercussions tied to disease-related losses propel the demand for these products, especially in areas where such illnesses are more common. This heightened demand is primarily driven by the imperative to safeguard animal health and ensure productivity levels within the livestock sector. Consequently, as animal health becomes increasingly prioritized, the market for antibiotics and antimicrobials continues to expand in response to these pressing challenges.

Restraints in the Animal Antibiotics and Antimicrobials Market

Shifting consumer preferences towards food safety and sustainability have led to a growing demand for antibiotic-free animal products. As consumers become more aware of the implications of antibiotic use in livestock, producers increasingly feel compelled to adopt antibiotic-free production practices. This transition adversely affects the demand for animal antibiotics and antimicrobials, as producers seek to align their operations with market trends and consumer expectations. Consequently, there is a notable movement towards exploring alternative disease prevention and growth promotion strategies in animal husbandry, emphasizing sustainability and the reduction of antibiotic usage, which further constrains the conventional antibiotics market.

Market Trends of the Animal Antibiotics and Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is witnessing a significant transformation fueled by a heightened focus on responsible use and the search for antibiotic alternatives. Increasing awareness of antimicrobial resistance (AMR) among consumers, alongside regulatory pressures, is prompting stakeholders to adopt innovative strategies that prioritize animal health while mitigating AMR risks. Consequently, there's a growing interest in alternatives such as probiotics, prebiotics, phytogenics, and vaccines, which are emerging as effective solutions to enhance livestock performance and welfare. This trend reflects a collective movement towards sustainable animal farming practices, ensuring food safety and public health while meeting the evolving expectations of consumers and regulators alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Antibiotics And Antimicrobials Market Size by Type & CAGR (2026-2033)

• Market Overview
• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other Antimicrobials And Antibiotics

Global Animal Antibiotics And Antimicrobials Market Size by Delivery & CAGR (2026-2033)

• Market Overview
• Premixes
• Oral Powder
• Oral Solution
• Injection
• Others

Global Animal Antibiotics And Antimicrobials Market Size by Animal & CAGR (2026-2033)

• Market Overview
• Food-Producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep And Goats
  • Other Food-Producing Animals
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

Global Animal Antibiotics And Antimicrobials Market Size & CAGR (2026-2033)

• North America (Type, Delivery, Animal)
  • US
  • Canada
• Europe (Type, Delivery, Animal)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Animal)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Animal)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Animal)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet Inc. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alltech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomin Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Animal Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adisseo (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations